Recurrent erythema multiforme in the setting of COVID-19 infection and oral candidiasis: A case for dysregulation of the T helper 17/interleukin 17 axis

Rebekah M Leigh; Luke Horton; Bonnie A Lee; Michelle S Min

doi:10.1016/j.jdcr.2024.04.029

Recurrent erythema multiforme in the setting of COVID-19 infection and oral candidiasis: A case for dysregulation of the T helper 17/interleukin 17 axis

JAAD Case Rep. 2024 May 9:49:73-76. doi: 10.1016/j.jdcr.2024.04.029. eCollection 2024 Jul.

Authors

Rebekah M Leigh¹, Luke Horton², Bonnie A Lee^{2

3}, Michelle S Min²

Affiliations

¹ Loma Linda University, School of Medicine, Loma Linda, California.
² Department of Dermatology, University of California Irvine, Irvine, California.
³ Department of Dermatopathology, University of California Irvine, Irvine, California.

No abstract available

Keywords: COVID-19; SARS-CoV-2; T helper 17; coronavirus disease 2019; interferon-gamma; interleukin 17; oral candidiasis; recurrent erythema multiforme; type 1 interferon.

Publication types

Case Reports